Sign in

NCT03384134Completed

Treating Pain in Children With Cancer: Pain Buddy

Mobile Technology to Improve Pain and Symptoms in Children With Cancer

Source: ClinicalTrials.gov · Last updated 24 Jul 2026

Brief summary (registry, in English)

The purpose of this study is to examine the feasibility of the ambulatory monitoring protocol, called Pain Buddy, in documenting children's pain, symptoms and quality of life while receiving outpatient chemotherapy. The long term goal of Pain Buddy is to help doctors, nurses, and parents get the information they need to give children treatments for pain and symptom management that work. Using Pain Buddy, we aim to quantify the prevalence and intensity of daily pain and symptom episodes in children at home, data that will be used to develop a psychosocial intervention to be delivered electronically to children at home with a goal of improving quality of life. Secondary aims also include examining children's quality of life pre- and post- Pain Buddy and satisfaction with the use of Pain Buddy. This project has the potential to improve the quality of life of tens of thousands of children suffering from cancer each year using transformative mobile health information technology based approach to pain assessment and management.

Status (registry)
Completed
Study type
Interventional
Enrollment
407 (actual)
First submitted
30 Nov 2017
Start date
1 Aug 2019
Primary completion date
14 Oct 2024
Lead sponsor
University of California, Irvine
NCT number
NCT03384134

What you commit to

  • Study type: Interventional
  • Participants enrolled: 407
  • From 1 Aug 2019 to the primary completion date, 14 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Cognitive impairment, such as a developmental delay or mental retardation that would prevent children from being able to use the Pain Buddy program.

Other

  • Children diagnosed with acute myelogenous leukemia (AML) or acute promyelocytic leukemia (APL) as the treatment protocols for these children are largely inpatient, precluding use of the intervention.

Who the study is looking for

  • Between the ages of 8-18 years
  • Currently undergoing outpatient treatment for cancer
  • Patients who are able to speak, read, and write in English. Parents who are able to speak, read, and write in English or Spanish
  • Have home internet access to use Pain Buddy (the internet will be used to securely send the pain information to the research team).

Age in the registry: 8 years to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of California Irvine
Coordinator of this site? Confirm its status
OrangeUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.